All Stories

  1. Overview on signal transduction cascades regulation roles of garlic and its bioactive constituents
  2. Rapid and automatic phenotyping of cells through their annexin-mediated enforced blebbing response
  3. Quercetin and MicroRNA Interplay in Apoptosis Regulation in Ovarian Cancer
  4. MicroRNA Regulation of TRAIL in Renal Carcinoma: Tiny Juggernauts at Work
  5. Ion Channels as Therapeutic Targets for Type 1 Diabetes Mellitus
  6. The applications of big data in molecular diagnostics
  7. Current and future molecular diagnostics of gastric cancer
  8. The applications of metabolomics in the molecular diagnostics of cancer
  9. Immunotherapeutic approaches in nasopharyngeal carcinoma
  10. The potential of circulating cell free RNA as a biomarker in cancer
  11. Application of NanoString technologies in companion diagnostic development
  12. The RNA Binding Protein HuR: a Promising Drug Target for Anticancer Therapy
  13. Early detection and monitoring of cancer in liquid biopsy: advances and challenges
  14. Mechanisms and Treatment Progress of Rituximab-Resistance in Diffuse Large B-cell Lymphoma
  15. Apoptosis and Anti-cancer Drug Discovery: The Power of Medicinal Fungi and Plants
  16. Tumor-secreted extracellular vesicles promote the activation of cancer-associated fibroblasts via the transfer of microRNA-125b
  17. The rise of human stem cell-derived natural killer cells for cancer immunotherapy
  18. Regulation of MicroRNAs by Phytochemicals: A Promising Strategy for Cancer Chemoprevention
  19. Implementation and new insights in molecular diagnostics for HIV infection
  20. Identification of novel drug targets for diamond-blackfan anemia based on RPS19 gene mutation using protein-protein interaction network
  21. Molecular subtyping of nasopharyngeal carcinoma (NPC) and a microRNA-based prognostic model for distant metastasis
  22. MicroRNAs as predictive biomarkers of response to tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma
  23. Long noncoding RNA identification in lymphoma
  24. Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies
  25. Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer
  26. Mass spectrometry-based proteomics in cancer research
  27. Applications of digital PCR in precision medicine
  28. Disease Biomarkers for Precision Medicine: Challenges and Future Opportunities
  29. Editorial: Molecular Diagnostics in the Detection of Neurodegenerative Disorders
  30. Expression of Iron-Related Proteins Differentiate Non-Cancerous and Cancerous Breast Tumors
  31. Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer
  32. Advances in Molecular Imaging of Locally Delivered Targeted Therapeutics for Central Nervous System Tumors
  33. MiR-30 Family Potentially Targeting PI3K-SIAH2 Predicted Interaction Network Represents a Novel Putative Theranostic Panel in Non-small Cell Lung Cancer
  34. The different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinoma
  35. Precision medicine in immune checkpoint blockade therapy for non-small cell lung cancer
  36. Patient-centric research transforms medicine from an inexact science into precision medicine.
  37. Neonatal Heart-Enriched miR-708 Promotes Proliferation and Stress Resistance of Cardiomyocytes in Rodents
  38. Epigenomics
  39. Molecular Connections of Aging and Cancer
  40. Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments
  41. Skin Cancer Epidemics in the Elderly as An Emerging Issue in Geriatric Oncology
  42. The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks
  43. Cancer and Aging - the Inflammatory Connection
  44. c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma
  45. Circulating Plasma MicroRNAs As Diagnostic Markers for NSCLC
  46. Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population
  47. Immune checkpoint blockade as a potential therapeutic target in non-small cell lung cancer
  48. Expression of CD40 is a positive prognostic factor of diffuse large B-cell lymphoma treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)
  49. An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A)
  50. Prognostic performance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: an updated meta-analysis of eleven reports
  51. Drug Transporters and Multiple Drug Resistance in the Most Common Pediatric Solid Tumors
  52. Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma
  53. Inhibition of CD147 expression by RNA interference reduces proliferation, invasion and increases chemosensitivity in cancer stem cell-like HT-29 cells
  54. Novel structural co-expression analysis linking the NPM1-associated ribosomal biogenesis network to chronic myelogenous leukemia
  55. MicroRNAs as regulators of airborne pollution-induced lung inflammation and carcinogenesis
  56. The role of microRNAs in toxicology
  57. Application of oncoproteomics to aberrant signalling networks in changing the treatment paradigm in acute lymphoblastic leukaemia
  58. Towards developing biomarkers for glioblastoma multiforme: a proteomics view
  59. Application of microRNAs in diabetes mellitus
  60. Colorectal cancer biomarker discovery and validation using LC-MS/MS-based proteomics in blood: truth or dare?
  61. Methenamine: a forgotten drug for preventing recurrent urinary tract infection in a multidrug resistance era
  62. Proteomics in translational cancer research: biomarker discovery for clinical applications
  63. Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers
  64. Biomarker discovery of nasopharyngeal carcinoma by proteomics
  65. Potential of antibody–drug conjugates and novel therapeutics in breast cancer management
  66. Stratification of clear cell renal cell carcinoma by signaling pathway analysis
  67. Putative biomarkers and therapeutic targets associated with radiation resistance
  68. Emerging techniques in molecular detection of circulating tumor cells
  69. Chinese Versus Western Medicine
  70. Epigenomics
  71. The role of acupoint stimulation as an adjunct therapy for lung cancer: a systematic review and meta-analysis
  72. Mapping the interactome of overexpressed RAF kinase inhibitor protein in a gastric cancer cell line
  73. Trastuzumab emtansine for advanced HER2-positive breast cancer and beyond: genome landscape-based targets
  74. Cell Budding from Normal Appearing Epithelia: A Predictor of Colorectal Cancer Metastasis?
  75. Targeting signaling pathways in lung cancer therapy
  76. Theranostics: rethinking postgenomic diagnostics
  77. MicroRNAs as therapeutic targets and their potential applications in cancer therapy
  78. Great potential of miRNAs as predictive and prognostic markers for cancer
  79. Genomic Sequence Analysis of EGFR Regulation by MicroRNAs in Lung Cancer
  80. Exploiting the therapeutic potential of microRNAs in human cancer
  81. Targeting the signaling pathways in cancer therapy
  82. Tube-Like Structures with Co-Expression of D2-40 and CD34: Newly Formed Vasculatures?
  83. Proteome profiling for the identification of lung cancer signatures
  84. Promises and challenges in developing miRNA as a molecular diagnostic tool for lung cancer
  85. Epigenetic alteration of microRNAs in feces of colorectal cancer and its clinical significance
  86. The role of inflammation in the pathogenesis of lung cancer
  87. Proteomics and translational medicine: molecular biomarkers for cancer diagnosis, prognosis and prediction of therapy outcome
  88. MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1
  89. Molecular diagnostics for monitoring and predicting therapeutic effect in cancer
  90. MicroRNAs in Cancer Translational Research
  91. Conquering cancer through discovery research
  92. MicroRNAs as therapeutic targets for lung cancer
  93. Recent progress in genetic variants associated with cancer and their implications in diagnostics development
  94. Supportive Cancer Care with Chinese Medicine
  95. An Omics Perspective on Cancer Research
  96. Role of miRNAs in lung cancer
  97. Cancer research on non-small cell lung cancer in smokers and non-smokers: snapshots from the AACR annual meeting 2009
  98. Updates in cancer research: insights from the AACR 100th Annual Meeting
  99. Transcatheter arterial chemoembolization combined with or without Chinese herbal therapy for hepatocellular carcinoma: meta-analysis
  100. Oncoproteomics: current trends and future perspectives
  101. OncomiRs: the discovery and progress of microRNAs in cancers
  102. Contribution of oncoproteomics to cancer biomarker discovery
  103. Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer
  104. Immunopharmacological Studies of Low Molecular Weight Polysaccharide from Angelica Sinensis
  105. Proteinchip